DLQ01: Dermaliq’s New Hair Loss Drug Starts Clinical Trials - HairScience
DLQ01, Dermaliq’s new topical drug for androgenetic alopecia, recently started phase 1b/2a clinical trials. Trials in men should finish at the end of 2023.
hairscience.org